Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Definium Therapeutics, Inc. | 75,187 | reported | 12 Jun 2025 | tx 7+162,269 |
| Forte Biosciences, Inc. | 31,000 | reported | 20 Mar 2025 | tx 5+304,514 |
| CELGENE CORP /DE/ | 11,675 | reported | 13 Jul 2010 | tx 36+370,176−123,578 |
| INCYTE CORP | 10,235 | reported | 16 Jul 2018 | tx 45+274,518−146,361 |
| HYPERION THERAPEUTICS INC | 9,800 | reported | 15 Apr 2013 | tx 1+9,800 |
| PROTEIN DESIGN LABS INC/DE | 1,387 | reported | 30 Dec 2020 | tx 19+616,108−496,050 |
| SEATTLE GENETICS INC /WA | 0 | reported | 14 Dec 2023 | tx 133+329,184−354,184 |
| COTHERIX INC | 0 | reported | 09 Jan 2007 | tx 4+6,060−30,300 |
| AERIE PHARMACEUTICALS INC | 0 | reported | 21 Nov 2022 | tx 16+101,949−38,145 |
| GW PHARMACEUTICALS PLC | 0 | reported | 05 May 2021 | tx 4+57,672−57,672 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2025 | GRANT_AWARD | Definium Therapeutics, Inc. | 75,187 | 0.00 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Forte Biosciences, Inc. | 31,000 | 0.00 USD | deriv |
| 05 Dec 2024 | PURCHASE | Definium Therapeutics, Inc. | 2,500 | 7.17 USD | |
| 23 Aug 2024 | PURCHASE | Definium Therapeutics, Inc. | 3,500 | 5.98 USD | |
| 20 Aug 2024 | GRANT_AWARD | Forte Biosciences, Inc. | 50,000 | 0.00 USD | deriv |
| 10 Jun 2024 | GRANT_AWARD | Definium Therapeutics, Inc. | 16,506 | 0.00 USD | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 49,003 | 229.00 USD | |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 9,260 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 8,750 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 9,260 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 9,260 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 9,260 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 2,044 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 7,038 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 3,171 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 3,462 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 3,676 | — | deriv |
| 19 Sept 2023 | GRANT_AWARD | Forte Biosciences, Inc. | 25,000 | 0.00 USD | deriv |
| 31 Jul 2023 | GRANT_AWARD | Forte Biosciences, Inc. | 148,514 | 1.01 USD | |
| 21 Jun 2023 | GRANT_AWARD | Definium Therapeutics, Inc. | 13,851 | 0.00 USD | |
| 21 Jun 2023 | GRANT_AWARD | Definium Therapeutics, Inc. | 37,594 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | Definium Therapeutics, Inc. | 13,131 | — | deriv |
| 31 May 2023 | GRANT_AWARD | SEATTLE GENETICS INC /WA | 2,044 | 0.00 USD | |
| 13 Feb 2023 | EXERCISE | SEATTLE GENETICS INC /WA | 8,750 | 36.70 USD | |
| 13 Feb 2023 | EXERCISE | SEATTLE GENETICS INC /WA | 8,750 | 0.00 USD | deriv |